OKYO Pharma Limited Increase Decrease In Cash And Cash Equivalents
OKYO Pharma Limited (OKYO) reported Increase Decrease In Cash And Cash Equivalents of $843.60 thousand for the 12-month period ending 2025-03-31, per its 20-F filed 2025-07-18.
Financial Statements › Notes
ifrs-full:IncreaseDecreaseInCashAndCashEquivalents · last filed 2025-07-18
| Period end | Increase Decrease In Cash And Cash Equivalents 12 month |
|---|---|
| 2025-03-31 | $843.60K 20-F · filed 2025-07-18 |
| 2024-03-31 | -$3.28M 20-F · filed 2025-07-18 |
| 2023-03-31 | $1.62M 20-F · filed 2025-07-18 |
| 2022-03-31 | -$3.32M 20-F · filed 2024-08-13 |
| 2021-03-31 | $6.21M 20-F · filed 2023-08-15 |
| 2020-03-31 | -$371.42K 20-F · filed 2022-08-15 |